搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
News Medical on MSN
9 天
Research improves diagnosis of genetic blood disorder beta-thalassemia
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
BioPharma Dive
1 天
Editas, changing course again, looks to partner lead CRISPR therapy
The gene editing company will focus on “in vivo” medicines, while seeking to license out or find a development partner for ...
FierceBiotech
1 天
Editas prioritizes in vivo gene therapies, looks to partner reni-cel
Editas Medicine is pushing its in vivo gene therapy strategy to the top of its agenda, boasting proof-of-concept data and ...
2 天
Editas Medicine Announces Progress Towards 2024 Goals, Including Achievement of In Vivo ...
Achieved in vivo preclinical proof of concept of hematopoietic stem and progenitor cell editing by utilizing Editas Medicine’s proprietary ...
precisionmedicineonline
21 小时
Editas Seeking Partner or Licensing Deal for Lead Sickle Cell, TDT Gene-Editing Treatment ...
The strategic shift will allow the firm to focus on advancing a newly announced in vivo gene-editing therapy candidate that's in preclinical development.
29 天
on MSN
Teen boy first in Michigan to get gene therapy treatment for blood disorder
"We have about eight patients that are in the insurance approval process," she said, for gene therapy treatments for beta ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈